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ABSTRACT 
 
Background: Bainbridge–Ropers syndrome (BRPS) is a recently described developmental 
disorder caused by de novo truncating mutations in the Additional sex combs-like 3 (ASXL3) 
gene. To date there have been fewer than ten reported patients.  
 
Objectives: Here we delineate the BRPS phenotype further by describing a series of twelve 
previously unreported patients identified by the Deciphering Developmental Disorders 
(DDD) study.  
 
Methods: Trio-based exome sequencing was performed on all twelve patients included in 
this study which found a de novo truncating mutation in ASXL3. Detailed phenotypic 
information and patient images were collected and summarised as part of this study. 
 
Results: By obtaining genotype: phenotype data, we have been able to demonstrate a second 
mutations cluster region within ASXL3. This report expands the phenotype of older patients 
with BRPS; common emerging features include severe intellectual disability (12/12), poor/ 
absent speech (12/12), autistic traits (9/12), distinct face (arched eyebrows, prominent 
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forehead, high-arched palate, hypertelorism and down-slanting palpebral fissures), (9/12), 
hypotonia (12/12) and significant feeding difficulties (12) when young. 
 
Discussion: Similarities in the patients reported previously in comparison to this cohort 
included their distinctive cranio-facial features, feeding problems, absent/limited speech, and 
intellectual disability. Shared behavioural phenotypes include autistic traits, hand-flapping, 
rocking, aggressive behaviour, and sleep disturbance.  
 
Conclusions: This series expands the phenotypic spectrum of this severe disorder and 
highlights its surprisingly high frequency. With the advent of advanced genomic screening, 
we are likely to identify more variants in this gene presenting with a variable phenotype 
which this study will explore. 
 
INTRODUCTION 
Large scale whole exome sequencing projects such as the Deciphering Developmental 
Disorders (DDD) Project have led to the discovery of a number of new genes underlying 
developmental disorders [1,2]. A reverse-genetics approach has proven particularly important 
for the discovery of disorders like Bainbridge–Ropers syndrome (BRPS), whose main clinical 
features are non-specific, especially when looked at in isolation or with a small number of 
patients. De novo mutation status is the first clue to potential pathogenicity of a given variant 
and such mutations are known to constitute a significant proportion of the underlying causes 
of moderate and severe intellectual disability (ID) [3]. 
  
ASXL1, ASXL2 and ASXL3 are human homologs of the Drosophila additional sex combs (asx) 
gene that encode putative polycomb proteins and are likely to act as histone 
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methyltransferases in complexes with other proteins [4]. Polycomb group proteins are 
implicated in embryogenesis and carcinogenesis through transcriptional regulation of target 
genes; the ASXL1 gene is thought to be one of the most frequently mutated genes in 
malignant myeloid diseases; ASXL is a scaffold protein interacting with methyltransferases 
and additional proteins of the epigenetic machinery [5,6]. Truncating mutations in ASXL1 
have been reported in association with Bohring-Opitz syndrome (BOS) which has phenotypic 
overlap with BRPS [7]. More recently, truncating mutations in ASXL2 were reported in 
association with a newly recognisable clinical phenotype [8]. 
 
Srivastava et al., 2016 showed that ASXL3 interacts with BAP1, a hydrolase that removes 
mono-ubiquitin from histone H2A lysine 119 (H2AK119Ub1) as a component of the 
Polycomb repressive deubiquitination (PR-DUB) complex [9]. The authors observed a 
significant increase in H2AK119Ub1 in ASXL3 patient fibroblasts, highlighting an important 
functional role for ASXL3 in PR-DUB mediated deubiquitination. Transcriptome analysis 
revealed >500 genes differentially expressed in ASXL3 patient fibroblasts relative to controls, 
and these genes were enriched for those involved with molecular processes impacting 
transcriptional regulation, development and proliferation. 
 
ASXL3 is expressed in similar tissues to ASXL1 including brain, spinal cord, kidney, liver, 
and bone marrow, but at a lower level [10]. The high correlation of expression patterns 
between ASXL1 and ASXL3 may account for some of the shared phenotypic features. 
 
Heterozygous, de novo loss-of-function mutations in ASXL3, underlying the Bainbridge–
Ropers syndrome (BRPS: OMIM #615485) have been described in 9 individuals to date [9, 
11-13]. The major phenotypic features described in the majority of patients so far include 
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failure to thrive, global developmental delay, feeding problems, hypotonia, dysmorphic 
features, profound speech delay and intellectual disability. Here we present genetic and 
phenotypic information on 12 previously unreported individuals with de novo truncating 
mutations in ASXL3, all of which were detected via the trio exome sequencing carried out by 
the DDD Project.  Additional clinical features of BRPS are likely to emerge with 
identification of additional patients through such large scale exome sequencing projects as 
described here. 
 
METHODS 
EXOME SEQUENCING 
In all twelve individuals identified via the DDD study, trio-based exome sequencing was 
performed on the affected individual and their parents, as previously described by Wright et 
al., 2014.  Each affected individual has also had a high-resolution analysis for copy number 
abnormalities using array-based comparative genomic hybridization (aCGH).  Putative de 
novo mutations were identified from exome data using DeNovoGear software  as described 
by Ramu et al., 2013 and were validated using targeted Sanger sequencing [14,15]. 
 
All recruited patients had the following de novo heterozygous pathogenic mutations 
identified which confirmed the diagnosis of Bainbridge-Ropers syndrome (OMIM: 615485): 
Patient 1: c.4330C>T, p.(Arg1444*) 
 Patient 2: c.1201del, p.(Ala401GlnfsTer8)  
Patient 3: c.1074T>A, p.(Tyr358*) 
Patient 4: c.4144C>T, p.(Gln1382*) 
Patient 5: c.1783C>T, p.(Gln595*) 
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Patient 6: c.3355dup, p.(His1119Profs*7) 
Patient 7: c.1082dup, p.(Leu362AlafsTer23)  
Patient 8: c.3635T>G, p.(Leu1212*)  
Patient 9: c. 3127_3128dup, p.(Gly1045Valfs*99) 
Patient 10: c.3178dup, p.(Arg1060Profs*50) 
Patient 11: c.1484insTGAA, p.(Asp497*)  
Patient 12: c.1491dup, p.(Asn498*)  
Mutation nomenclature is according to HGVS recommendations (http://varnomen.hgvs.org/), 
and is based on reference transcript NM_030632.2. 
 
PATIENT ASCERTAINMENT 
All twelve individuals were recruited via UK NHS Regional Genetics Services onto the 
Deciphering Developmental Disorders (DDD) Project (www.ddduk.org). As part of that 
study, patient and parental samples receive array CGH and exome sequencing analysis and 
findings of potential clinical significance are reported back to recruiting clinical geneticists. 
Any significant findings are usually validated by an accredited UK NHS diagnostic genetics 
laboratory before being reported to patients and their families; mutations described in this 
paper have been validated as such. Patient phenotype information was provided to the authors 
via Clinical Geneticists from several UK NHS genetics services. See Table 1 for a summary 
of the clinical and molecular findings. 
 
RESULTS 
ASXL3 MUTATIONS 
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Previously reported truncating ASXL3 mutations cluster mainly within the 5’ end of exon 11 
between codons 404 and 659. This region lies in-between the N-terminal protein scaffolding 
functional domains of the gene and the C-terminal chromatin/DNA-targeting functional 
domain. Srivastava et al., 2016 reported two mutations significantly 3’ to this main cluster 
region, at codons 1122 and 1444 [9]. One of the patients (Patient 1) within our cohort carries 
the same c.4330C>T p.(Arg1444*) mutation as the patient reported by Srivastava et al, 2016 
suggesting it as a possible recurrent mutation.  
 
Among our cohort, 5/12 (Patients 2, 3, 7, 11, 12) of the mutations could be described as 
occurring within the originally reported mutation cluster region, 1/12 (Patient 5); c.1783C>T, 
p.(Gln595*),  maps more 3', and the remaining 6 (Patients 1, 4, 6, 8, 9, 10) lie further 
downstream within the more 3’ region, reported by Srivastava et al, 2016, which could be 
considered as a distinct mutation cluster region, extending between codons 1045 and 1444 
[9]. All these mutations are publicly available on www.ddduk.org.  
 
PATIENT PHENOTYPES 
 
Antenatal history and birth: Polyhydramnios and concerns regarding poor growth were 
noted in 1/12 but otherwise unremarkable. For 9/12 patients, a caesarean section was 
performed, mostly due to breech presentation. All 12 patients had an average birth weight and 
apart from 4/12 patients who were admitted to the Neonatal unit for respiratory difficulties/ 
apnoea, the remainder neonatal period was uneventful. 
 
Feeding problems: Consistent with previous reports, 9/12 patients were reported to have 
significant feeding problems, often including gastro-oesophageal reflux, requiring 
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intervention in the form of nasogastric tube feeding, fundoplication. The majority were 
described as having failure to gain weight with poor appetite.  
 
Growth: Patients reported here had consistent poor growth with weight and height below the 
0.4
th
 centile and relative microcephaly (7/12). This is in keeping with previously reported 
literature. 
 
Craniofacial features: 9/12 have a high-arched palate, distinctive facial dysmorphism as 
described below (Figure 1). 
 
Dysmorphic features:  10/12 had down-slanting palpebral fissures and 2 had up-slanting 
palpebral fissures; both have previously been reported but down-slanting seems to be more 
common. A long, tubular nose with a prominent nasal bridge is apparent in most. Most of the 
individuals have a broad nasal tip with low columella. The mouth is wide with full (everted) 
lower lip. Hypertelorism, a narrow head shape with prominent forehead, ‘pencilled’ and/or 
high-arched eyebrows and crowded teeth were also common features. 
 
Other significant features: 12/12 had significant hypotonia, 7/12 had strabismus of varying 
severity. 3 patients had seizures, previously reported in 2 other ASXL3 patients. Patient 2 had 
scoliosis requiring surgery. 3 patients had arachnodactyly, not previously reported in any 
ASXL3 patients. 3/12 appears to have a Marfanoid habitus with arachnodactyly, tall stature, 
pes planus and scoliosis. 
 
Intellectual Disability: The level of intellectual disability ranged from moderate to profound 
but more likely at the severe end of the spectrum. All patients had ID of varying degree; 
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generally severe. Most were very delayed in walking unassisted and 2 remained entirely non-
ambulant. 9/12 patients were entirely non-verbal, including Patient 2 at 22 years of age. 9/12 
patients had either formally diagnosed autism or autism spectrum disorder, or were described 
as having autistic features. 3 patients exhibited hand-flapping, rocking. All the patients were 
in a special needs school requiring significant help. 
 
Relevant negative findings: Seizures does not appear to be a major feature, seen in only 
3/12 patients and generally well-controlled absence seizures; MRI-brain imaging only 
showed non-specific features with white matter changes (3/12) and vermis hypoplasia (1/12) 
which is relevant given the significance of intellectual disability in this cohort of patients. 
 
DISCUSSION 
The recently described Bainbridge–Ropers syndrome (BRS; OMIM # 615485), associated 
with de novo truncating mutations in the Additional sex combs-like 3 (ASXL3) gene (OMIM * 
615115), shows phenotypic overlap with Bohring-Opitz syndrome, which is associated with 
de novo truncating mutations in ASXL1 (OMIM * 612990). Bohring-Opitz syndrome (BOS; 
OMIM # 605039) is characterised by distinct craniofacial features and posture, severe 
intellectual disability, feeding problems, small size at birth, and failure to thrive. 
 
Bainbridge et al. 2013 reported a series of four unrelated probands with de novo, 
heterozygous, truncating mutations in ASXL3, sharing similar phenotypes, including severe 
feeding difficulties, failure to thrive, and neurologic abnormalities with significant 
developmental delay [11]. More recently, truncating mutations in ASXL2 were reported as 
being associated with a newly recognisable syndrome with overlapping features to BOS and 
BRPS [8]. In this report, the authors described six unrelated patients with de novo truncating 
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mutations in ASXL2 with shared clinical features including intellectual disability, 
macrocephaly, distinct facies, facial nevi, feeding difficulties and hypotonia. Comparison of 
patients reported in this with BRPS shows the facial dysmorphism to be more similar to BOS 
with macrocephaly, arched eyebrows, synophrys and facial nevi rather than with BRPS. 
Other distinguishing features included macrocephaly, congenital heart disease, structural 
brain malformations and seizures in these patients, which differs to the BRPS cohort. 
However, there are emerging similarities within this group of conditions, including 
hypotonia, feeding difficulties and intellectual disability, which will become more apparent 
as more patients are reported with ASXL2 mutations. 
 
To date there have been fewer than ten reported patients with de novo truncating ASXL3 
mutations. Emerging similarities include, distinctive cranio-facial features with arched 
eyebrows, prominent forehead, high-arched palate, hypertelorism with down-slanting 
palpebral fissures; significant feeding difficulties needing support; profound/ severe 
intellectual disability; emerging behavioural phenotype consisting of autistic traits, hand-
flapping, rocking, aggressive behaviour, sleep issues with absent/ poor speech. Table 1 
provides a comprehensive summary of reported features in this cohort: predominant features 
in the phenotype are normal pregnancy, higher incidence of caesarean section due to breech 
presentation, relative microcephaly, significant feeding difficulties, facial dysmorphism , 
high-arched palate, strabismus, hypotonia, skeletal features including a Marfanoid habitus 
(especially in the older patients), severe intellectual disability with poor/ absent speech, 
autistic traits, need for special education. Seizures, structural malformations of internal 
organs including the brain, kidneys do not appear to be a predominant part of their 
phenotype. However, this is likely to be revised/ expanded as more patients are described 
with BRPS. 
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There is a wide age range (4-22 years), this being the first report of older patients with BRPS. 
The older patients in this cohort all have moderate to severe ID, autistic features, attended a 
special needs school and are in assisted living. Seizures are a component but not a 
predominant part of their phenotype and they do not appear to have any major structural 
associations with this diagnosis as they have grown older. The behavioural phenotype 
appears to be in keeping with other severe developmental disorders with absent/ poor speech, 
periods of agitation, frustration and poor sleep. 
 
Though Bainbridge-Ropers syndrome (BRPS) is likely to remain a challenging syndrome to 
recognise clinically, this cohort of patients has enabled further delineation and expansion of 
the phenotype. Results of analysis of the first several thousand patient trios within the DDD 
Project suggests that de novo ASXL3 mutations are among the more common underlying 
causes of disease within the DDD cohort (at time of writing, ASXL3 ranks number 12 out of 
the top 20 genes in which a pathogenic de novo mutation has been found), and therefore it is 
expected that there will be many more BRPS patients diagnosed in the near future, further 
defining the associated clinical spectrum.  
 
Our cohort has also firmly established a second, 3’ mutational cluster region within ASXL3 
which may be of significance to disease mechanism. In regards to this, an ASXL3 mRNA 
transcript carrying the c.1448dupT truncating mutation has previously been shown to be 
prone to nonsense-mediated decay, with resultant reduction in expression of ASXL3 [6]. 
Consistent with previous reports and consistent with this disease mechanism, the cohort of 
patients described here do not show a correlation between phenotypic features or severity and 
mutation position. It has previously been noted that several truncating mutations in ASXL3 
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are described in databases composed of sequence variants from phenotypically normal 
individuals (see Figure 2). To date, there are 4 such mutations within the ExAC dataset, each 
identified within only one individual within the dataset, and they occur both 5’ to the original 
5’ mutational cluster region (MCR) and 3’ to the new 3’ cluster region, and also in between 
the two cluster regions. The explanation for these mutations is as yet uncertain. 
 
We have also been able to collect phenotypic data from several patients with previously 
unreported missense variants in ASXL3 (including p.Ser86Ala, p.Lys1026Asn, p.Arg933Trp 
and p.Ser720Cys). However, in each case the variants were inherited from clinically 
unaffected parents and the patients had a very dissimilar presentation in comparison to the 
clinical presentation associated with ASXL3 loss-of-function mutations. Without further 
investigation it cannot be ruled out that these variants are of clinical significance, however it 
is unlikely that they are the sole cause of the phenotype observed in these patients. It is 
possible that they represent rare polymorphisms. In support of this, all of these variants are 
found, albeit at low frequency, within healthy control populations (Exome Aggregation 
Consortium, Cambridge, MA, URL: http://exac.broadinstitute.org).  
 
Ropers et al., 2015 previously highlighted the presence of truncating mutations in ASXL3 and 
several other dominant genes for intellectual disability or related disorders, within healthy 
control populations, suggesting the possibility of incomplete penetrance for truncating 
mutations within these genes [14]. This included ASXL1, for which 56 such mutations were 
found within the ExAC dataset. 
 
Whilst it cannot be entirely ruled out that truncating ASXL3 mutations exhibit incomplete 
penetrance, the number of such mutations (four) found within the ExAC data is still relatively 
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small compared to ASXL1 and the other genes examined, and the list of reported patients with 
ASXL3 truncating mutations that have a Bainbridge-Ropers syndrome consistent phenotype is 
growing.  
 
Therefore, it seems reasonable that all four of these ASXL3 mutations may be accounted for 
by the various other explanations that Ropers put forward, for example, two of the mutations 
occur at the extreme 3’ end of the gene, and may therefore escape nonsense mediated decay 
(NMD), retaining protein activity.  Bainbridge et al., 2013 suggested that mutations may arise 
post-zygotically or during later embryogenesis and thus the phenotypic variability or 
incomplete penetrance may be explained by mosaicism [11]. With the increasingly wider 
access of high read-depth exome sequencing for genetic diagnosis of children with 
developmental disorders it seems likely that this question will eventually be answered as 
more data emerges.  
 
CONCLUSIONS 
In this series, we report 12 patients with ASXL3 loss-of-function de novo variant and expand 
the phenotype of Bainbridge-Ropers syndrome. New specific associated clinical features 
have become apparent, such as hypotonia, Marfanoid habitus, and arachnodactyly. This 
cohort is consistent with previously reported patients with regards to the facial features and 
also confirms pertinent negative features such as lack of significant findings on brain 
imaging, and lack of seizures. This research further reiterates the power of whole exome 
studies in conjunction with a detailed clinical phenotype in providing an explanation for our 
patient’s difficulties and a unifying diagnosis for their concerns.  
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FIGURE AND TABLE LEGENDS 
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Figure 1: Facies of individuals with ASXL3 loss-of-function mutations reported herein 
demonstrating down-slanting palpebral fissures, a long, tubular nose with a prominent nasal 
bridge is apparent in most. Most individuals have a broad nasal tip with low columella. The 
mouth is wide with full (everted) lower lip; hypertelorism, a narrow head shape with 
prominent forehead, ‘pencilled’ and/or high-arched eyebrows. 
Figure 2. Map of ASXL3 mutations reported to date. Mutation nomenclature according to 
HGVS guidelines (http://varnomen.hgvs.org/) using NCBI reference  Transcript 
NM_030632.3).  
Table 1: Clinical features of twelve previously-unreported patients with ASXL3 loss-of-
function mutations reported herein in comparison to previously reported patients with 
Bainbridge-Ropers syndrome. 
Supplementary section containing a detailed clinical summary of all patients reported here. 
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 Bainbridge et al., 
(2013)* Patient 1 
Bainbridge et al., 
(2013)* Patient 2 
Bainbridge et al., 
(2013)* Patient 3 
Bainbridge et al., 
(2013)* Patient 4 
Dinwiddie et al., 
(2013) 
Srivastava et al., 
(2016) 
Patient 1 
Srivastava et al., 
(2016) Patient 2 
Srivastava et al., 
(2016) Patient 3 
Hori et al., 2016 Patient 1 
Decipher ID NA NA NA NA NA NA NA NA NA 274629 
ASXL3 Variant c.1210C>T, 
p.Gln404* 
c.1396C>T, 
p.Gln466*  
 
c.1422dup, 
p.Glu475*  
 
c.1978_1981del, 
p.Asp660Asnfs*16 
c.1897_1898delC
A, 
p.Gln633Valfs*1 
c.4330C>T, 
p.(Arg1444*) 
c.3664C>T, 
p.Q1122X 
c.1448dupT, 
p.Thr484Asnfs*5 
c.3039+1G>A 
c.4330C>T 
p.(Arg1444*) 
Age NR 3yrs 5yrs 3.5yrs 6yrs 5.5yrs 4yrs 13m 5yrs 
21yrs 
Sex NR M F F F F M M F M 
Height -4.5 to -5SD <1% Normal Reduced 10th- 25th  24th  NR NR -3 SD(<<0.4th) 
50th 
Weight -4.5 to -5SD <1% Normal Reduced 10th – 25th  24th  NR NR -3.4SD (<0.4th) 75th-91st  
OFC -4.5 to -5SD <1% Normal Reduced 3rd  4th  NR NR -3 SD (<<0.4th) 25th  
Pregnancy IUGR Normal Normal Normal Normal IUGR Normal Normal Normal Normal 
Birth Normal Breech CS Normal CS; Breech; BW- 
1.88kg 
Normal; BW- 2.25kg Normal; BW- 
3.4kg 
Normal; BW- 3.1kg Normal; BW- 
2.43kg 
Elective CS ; breech; 
BW-3.7kg 
Neonatal Unit NR NR NR NR Yes No No No Yes, 2/52 Yes, 5/7  
Gestation Term Term Term Term 34 weeks Term Term Term Term Term 
Feeding 
Difficulties 
Yes Yes No Yes Yes Yes Yes Yes Yes 
No 
Cranio-facial 
features 
Arched, thin 
eyebrows, 
microcephaly 
Arched, thin 
eyebrows, 
microcephaly 
Frontal bossing, 
short nose 
Arched eyebrows, 
hypoplastic ale nasi 
Microcephaly, 
trigonocephaly, 
epicanthic folds 
Low-set ears, short 
nose, micrognathia 
Anteverted nares, 
small chin 
NAD Prominent 
forehead, thick 
eyebrows 
Long tubular nose, thin 
upper lip 
Downslanting 
palpebral 
fissure 
NR Yes Yes Yes No Yes Yes Yes Yes 
Yes 
Palate NR NR NR Narrow, high-arched Normal NR NR NR NR High-arched 
Strabismus NR NR   No No No No Yes No 
Hypotonia Yes Yes Yes Yes Yes Yes Yes Yes No 
Yes 
Marfanoid 
habitus 
NA NR NR NR No No No No No 
Yes 
Skeletal 
features 
Ulnar deviation Ulnar deviation Normal Ulnar deviation Metopic 
synostosis 
NR Ulnar deviation No camptodactyly 
arachnodactyly 
ID Severe, died at 
9/12 
Severe Moderate Severe Severe Moderate Moderate Moderate Moderate 
Moderate 
Seizures NR NR NR NR No Yes No Yes No 
No 
Autism/ ASD NR NR NR NR Yes NR NR NR Yes Yes (and Tourette's 
syndrome) 
Structural 
anomalies 
NR NR NR White matter 
changes on MRI 
Pulmonary 
stenosis 
White matter changes 
on MRI 
Vermis hypoplasia White matter 
changes on MRI 
No 
No 
Dev. Outcome Delayed Delayed Delayed Delayed Delayed Delayed Delayed Delayed Delayed 
Delayed 
Speech and 
language 
NA Absent Absent Absent Absent Absent Few words Absent Delayed, few 
words 
Delayed, needed 
speech therapy 
Behaviour NA NR NR NR Poor sleep; 
aggressive 
NR Aggressive NR Moderate autism, 
poor sleep 
Tourette's syndrome, 
autistic traits 
Hand flapping NA NR NR NR NR NR NR NR NR Yes 
Educational 
support 
NR NR NR NR NR NR NR NR NR 
Yes: SEN 
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 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6  Patient 7 Patient 8 Patient 9 Patient 10  Patient 11  Patient 12  R/V 
Decipher ID 275029 274593 278695 261513 265854 271912 275860 265908 259240 272591 208772  
ASXL3 
Variant 
c.1201del 
p.(Ala401fs) 
c.1074T>A 
p.(Tyr358*)  
c.4144C>T 
p.(Gln1382*)  
c.1783C>T 
p.(Gln595*) 
c.3355dup 
p.(His1119fs) 
c.1082dup 
p.(leu362fs) 
c.3635T>G 
p.(Leu1212*) 
c.3127_3128dup 
p.(Gly1045fs) 
c.3178dupC, 
p.(Arg1060fs)  
c.1484insTGAA, 
p.(Asp497Ter) 
c.1491dup 
p.(Asn498*) 
 
Age 22yrs 6yrs 6yrs 9yrs 6yrs 10yrs 20yrs 4yrs 3mths 9yrs 19yrs 8yrs  
Sex F F F M M Male Female Female Male Female Male  
Height <0.4th  25th  9th  25th  75th-91st  50th  2nd  50th  25th   9th  50th   
Weight 0.4th  50th  <0.4th    25th-50th  50th  >99th  <0.4th  0.4th  9th   2nd  25th   
OFC <0.4th  <0.4th  0.4th-2nd    0.4th-2nd  0.4th  <25th  <0.4th  0.4th  <0.4th  0.4th  50th   
Pregnancy 
Polyhydramnios Normal Normal Normal Normal Normal IVF (twin well) Normal 
Mild renal pelvis 
dilatation at 20/40, 
resolved postnatally 
Normal Normal 
11/12 
Birth Em CS; breech; BW- 
2.98kg 
Em CS; BW- 
3.12kg 
Normal; BW- 
2.7kg 
Em CS; breech; 
BW- 3.5 kg 
Induced Normal Induced, Em CS El CS; breech 
El CS; extended 
breech; BW- 3.4kg 
Normal; BW- 3.4 
kg 
El CS; breech 
9/12 
CS 
Neonatal Unit Yes, 5/7  No No No Yes, apnoea No No No No Febrile No 4/12 
Gestation Term Term Term 39/40 42/40 41 weeks 40 weeks 38/40 38/40 40 weeks 38 weeks  
Feeding 
Difficulties 
Yes: Poor 
suck/swallow, GOR, 
fundoplication at 3yrs 
No 
Yes: Hx of 
GER, feeding 
issues, poor 
appetite 
Yes: Stopped 
breast feeding at 
4mths due to poor 
weight gain 
Yes: gastrostomy 
fed; GOR; 
fundoplication 
No 
Yes: Severe, NG 
fed for 2 yrs 
Yes Yes: GOR; FTT 
Yes: frequent 
vomiting as a 
baby 
Yes 
9/12 
Cranio-facial 
features hypertelorism, 
hirsutism, finely 
'pencilled' eyebrows 
hypertelorism, 
down-slanting 
palpebral fissures 
thick eyebrows, 
prominent 
forehead, high 
nasal bridge, 
deep set eyes 
posteriorly rotated 
ears, dental 
overcrowding, 
long jaw 
prominent nasal 
bridge, tongue tie, 
micrognathia 
synophrys, finely 
'pencilled' eyebrows, 
micrognathia, 
prominent central 
incisors 
scaphocephaly, 
prominent nasal bridge, 
mild synophyrus, 
crowded teeth, high 
palate 
_ 
long face with 
slightly upslanted 
palpebral fissures 
and twin hair crowns 
Extremely slim 
and long limbed 
_ 
9/12 
Downslant pf No Yes Yes No No Yes No No No Yes Yes 6/12 
Palate 
High-arched 
Narrow, high-
arched 
NAD High-arched High-arched NAD 
High-arched, bifid 
uvula 
Normal High-arched 
High-arched, 
narrow palate 
High-arched 
9/12 
Strabismus 
Yes, divergent  Yes Yes No Yes No 
Bilateral, 
convergent/divergent 
Yes No No Yes 
7/12 
Hypotonia Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 12/12 
Marfanoid 
habitus 
No No Yes No No No No No _ Yes No 
3/12 
Skeletal 
features 
Camptodactyly 4th 
fingers, short distal 
phalanx of thumbs, 
scoliosis  
hyperflexible 
elbows 
arachnodactyly No No No 
narrow small feet, pes 
planus 
No postural scoliosis 
Malar hypoplasia, 
long slim hands 
and feet 
No 
7/12 
ID Profound Moderate Severe Severe Severe Moderate/Severe Severe Moderate _ Severe Severe 12/12 
Seizures 
Yes; absences No No No No No 
Possible absences 6y; 
GTCS from 11y 
No No 
GTCS in 
childhood 
Yes 
3/12 
Autism/ ASD 
Likely; not formal No ASD 
Likely (no formal 
Dx) 
No Autism  Autism (Dx 6yrs) No ASD, SDP, ADD  
Likely (no formal 
Dx) 
Yes 
9/12 
Structural 
anomalies 
unilateral choanal 
stenosis 
No No No No No 
Bifid nail, 
laryngomalacia, 
intestinal malrotation 
No No No No 
2/12 
Speech and 
language 
only noises v. delayed v delayed 
makes noises and 
uses Makaton 
Communicates by 
looking at objects 
Non-verbal, displays 
comprehension 
Only simple sounds, no 
words: uses PECS 
delayed Uses PECS _ 
no expressive 
language 
12/12 
Behaviour Autistic traits, 
hyperventilates 
No  autistic traits No 
Periodic agitation 
with self-harming 
Poor sleep; difficult 
behaviour 
Frustrated; hand 
flapping when upset 
_ Pica; sleep disorder  Grunting; bruxism generally placid 
9/12 
Hand 
flapping 
Yes No No No No No Yes 
shakes and claps 
hands 
head rocking and 
clicking 
_ Yes 
3/12 
Educational 
support 
Yes: special school 
Yes: special 
school 
Yes: special 
school 
Yes: special 
school 
Yes: special school Yes: special school Yes: special school 
Yes: special 
school 
Yes: SEN Yes: SEN 
Yes: special 
school 
12/12 
M: Male; F: Female; NR: Not reported; NA: Not applicable; PD: Palpebral fissures; ASD: Autism spectrum disorder; ID: Intellectual disability; Dx: Diagnosis; NAD: No abnormality detected; BW: Birth weight; Em CS: Emergency caesarean section; El CS: Elective caesarean section; SEN: Special educational needs; GOR: gastro-oesophageal reflux; FTT: Failure to thrive; GTCS: 
generalised tonic-clonic seizures; PECS: Picture exchange communication system; -: Not known; R/V: review summary 
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SUPPLEMENTARY MATERIAL  
 
Clinical Description 
 
Patient 1: This 21-year old patient was the first child of healthy, non-consanguineous, White 
European parents.  He has a younger sibling who is fit and well.  The family history was 
complicated by paternal history of TIA’s (transient ischaemic attacks), although MRI-brain 
scan in the father was reported as normal.  He was conceived naturally and there were no 
concerns during the pregnancy.  He was born full-term with a birth weight of 3699 grams by 
elective cesarean section due to breech presentation.  He was initially admitted to the 
Neonatal unit due to a lung collapse needing chest drain insertion and ventilatory support for 
5 days.  He was discharged home at 11 days of age and there were no reported feeding 
difficulties.  
 
Concerns were initially identified when his developmental milestones were delayed: he 
smiled at 20-weeks of age, sat up at 12-months of age and walked at 23-months of age.  His 
speech was particularly delayed in that his first words were at 18-months of age and he 
needed speech therapy.  He was also diagnosed with an Autistic spectrum disorder (ASD) and 
went on to attend a special needs school.  He was subsequently diagnosed with Tourette’s 
syndrome, needing treatment with Aripiprazole.  A MRI-brain scan was reported as grossly 
normal with minor terminal myelination defects.  There were no concerns with his general 
health and although, he had 2 episodes of febrile seizures as a child, he does not suffer from 
any seizures. 
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On examination, he had the following dysmorphic facial features: relatively long, tubular 
nose, thin upper lip, down-slanting palpebral fissures (Figure A).  Growth parameters at the 
age of 15-years were: height 172.2 cm (75
th
 centile), weight 60.3 kg (75
th
 centile), and ofc 
54.6 cm (9
th
-25
th
 centiles).  His lower limb reflexes were brisk with down-going plantar 
responses but the rest of his neurological examination was unremarkable.   Previous 
investigations have included: normal 60K Array; normal Fragile-X and GCH1 testing.   
 
Patient 2: This 22-year old patient was the second of 5 children born to healthy, non-
consanguineous White European parents. There was no relevant family history. She was 
conceived naturally. The pregnancy was complicated by polyhydramnios. She was delivered 
at 38 weeks gestation by elective caesarean section for breech presentation , with a birth 
weight of 2980 grams. She was admitted to the neonatal unit because of poor feeding. She 
was noted to have a unilateral choanal stenosis and a small jaw. She was breast fed initially 
but failed to thrive and was switched to bottle feeding with added polycal.  
Concerns were raised within the first 3 months about lack of alertness, reduced visual 
behaviour and hypotonia. She had severe gastro-oesophageal reflux requiring fundoplication 
at 3 years and a gastrostomy primarily to vent swallowed air. She sat at 9 months but has 
never been ambulant but will weight bear with support. She can reach and handle things with 
both hands and can press switches. She can feed herself with hands or spoon and enjoys food. 
Vocalisation is limited to noises and clicks. She is able to use picture exchange to choose 
between 2 options. Understanding is very limited and is situational. There is very poor eye 
contact and gaze avoidance and she will explore objects non-visually. She does enjoy 
observing others. Hearing appears normal. She displays head rolling, thumb twiddling, 
bruxism, mouthing and eye pressing behaviours. 
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Menarche was at 10 years but menstruation has been infrequent. She required surgical 
rodding for scoliosis. Absence seizures and occasional partial seizures are treated with 
Sodium Valproate.  
 
On examination, she had hypertelorism with marked divergent squint, finely pencilled 
eyebrows, high-arched palate and hirsutism (Figure B). She had contractures of the 4
th
 fingers 
with shortened distal phalanx of the thumbs and out-turning of the feet. She tended to adopt a 
head-tilted posture. Growth parameters at 19 years were height 125cm (<<0.4
th
 centile) 
weight 41kg (<0.4
th
 centile) and ofc 51.5cm (<0.4
th
 centile). 
 
Previous investigation have included: normal 60K array, normal molecular testing of MECP2, 
cranial CT scan. 
 
Patient 3: This 6-year old patient was the second child of healthy, non-consanguineous White 
European parents. She has an older sibling who has severe cerebral palsy. There is nothing 
else of significance in the rest of the family history. She was conceived naturally and there 
were no concerns during the pregnancy. She was delivered by planned caesarean section at 39 
weeks gestation with a birth weight of 3118 grams. 
 
Concerns were initially identified when her developmental milestones were delayed: she sat 
up at approximately twelve months; had previously rolled at around the age of nine months.  
At the age of eighteen months, she was pulling to stand and cruising around the furniture. She 
walked independently at 3 years.  She was toilet-trained at 4 years. She had no words until 5 
years, but said “dada” from around 12 months. She has relatively good social communication 
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skills despite her speech difficulty.  She wears glasses for hypermetropia and has a mild left 
convergent squint. There are no concerns with her general health. 
 
On examination, she was dysmorphic with hypertelorism, down-slanting palpebral fissures 
(Figure C), her height at 18 months was between the 25th and 50th centiles, her weight 
between the 9th and 25th centiles and ofc between the 0.4th and 2nd centiles, at 6 years her 
height and weight were on 25th centile and ofc just below 0.4th centile. Parental head 
circumferences are both on the 75th centile.   
 
Previous investigations have included: chromosomes, 15q methylation, SMN testing, full 
metabolic work-up all of which were normal.  
 
Patient 4: This 6-year old patient was the third child of healthy, consanguineous Libyan 
parents. There was no relevant family history. She was conceived naturally and the pregnancy 
was normal. She was delivered at term, with a birth weight of 2700 grams. There were no 
neonatal concerns other than gastro-oesophageal reflux.  
 
Concerns were raised about her motor development which was mildly delayed: she sat at 9 
months and walked at 20 months. However, she had significant speech delay and did not 
progress from the babble stage. When assessed at 6 years, she still did not have any formal 
speech and her understanding of language was also very limited. Her behavioural profile was 
of particular concern: she showed poor social interaction and communication; she had no 
sense of danger; she had a short attention span and was easily distractible; she required 
Melatonin to aid sleep. She had a number of repetitive mannerisms such as shaking her head 
from side to side. Aged 4.5 years, she underwent a formal behavioural assessment which 
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confirmed a diagnosis of Autism Spectrum Disorder. She had a divergent squint but otherwise 
her vision and hearing were normal.  Her general health was good other than poor weight 
gain.   
 
On examination, she had a thick head of hair and thick eyebrows. She had a prominent 
forehead with a high nasal bridge and deep set eyes (Figure D). She had a mild pectus 
deformity but no scoliosis. She was of very slim build with slender hands and feet. Growth 
parameters at 6 years were height 109.8cm (9
th
 centile), weight 13.5kg (<0.4
th
 centile) and 
OFC 48.8cm (0.4
th
 centile). 
 
Previous investigations included microarray which showed a paternally inherited 3.2 Mb gain 
at chromosome 4p15.1 which contained no known dosage sensitive genes and so was thought 
to be of unlikely clinical significance. Neurometabolic investigations were also completed and 
were normal. MRI-brain scan performed aged 3.5years showed minor periventricular high 
signal of uncertain significance. 
 
Patient 5: This 9-year old patient was born following a normal pregnancy, breech 
presentation was diagnosed. He was delivered by elective Caesarean section. His unaffected 
brother had also been a breech presentation. His birth weight was 3500 grams and he was in 
good condition. There were no concerns with feeding or growth at first but over the first few 
months, feeding deteriorated and he failed to thrive. At four months of age, breast feeding was 
stopped and he was given formula feeds with calorie supplementation. At 6 months of age, he 
had an episode of bronchiolitis associated with significant weight loss. He recovered from this 
and there were no problems with weaning to solid food.  
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In terms of his development, he developed a social smile at 6 weeks of age but all other 
milestones were delayed. He had low muscle tone, sat late and walked independently at 
approximately 4 years of age. He has no recognisable words but makes sounds and 
communicates using Makaton. He has not had any seizures. He does not demonstrate hand 
flapping. He does periodically have tics or habits which resolve after a time. He has not been 
formally assessed for autism. He is generally a sociable boy.  
 
On examination at 9-years of age, his growth parameters were, OFC 51.7 cm (2
nd
 centile), 
height 128.0 cm (9
th
 centile), and weight 26.0 kg (9
th
 centile). He has a narrow head shape 
with a prominent forehead but no overt scaphocephaly and his cranial sutures are normal. He 
has a high-arched palate with dental overcrowding and a long jaw (Figure E). Physical 
examination was otherwise unremarkable. 
 
Patient 6: This 6-year old boy was born at 42-weeks gestation following a normal pregnancy 
by normal delivery. He was found to have micrognathia with a high-arched palate, a 
prominent nasal bridge and long, slender fingers and toes (Figure F). He had a prominent 
metopic ridge but a skull X-ray showed normal sutures. In the first few days of life, he 
developed feeding difficulties associated with palatal-pharyngeal incoordination. Severe 
reflux and feeding difficulties necessitated fundoplication and gastrostomy. He had truncal 
and limb hypotonia. At 6 years of age, cyclical periods of agitation developed which were 
subsequently found to be due to Crohn’s disease. 
 
In terms of his development, he smiled at an early age but all subsequent development was 
delayed. He sat independently at approximately 6 years of age. At 9 years of age, he can stand 
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with support, is not walking, vocalises a little but with no words but has some understanding. 
He has long, slender limbs. 
 
Microarray was normal. FISH studies on skin fibroblasts excluded trisomy 8 mosaicism. A 
CT-brain was normal.   
 
Patient 7: This 10-year old patient was born at 41 weeks following an unremarkable 
pregnancy. Birthweight was 3090 grams and there were no initial concerns. Concerns were 
first raised at the age of 10 months with a suggestion of motor delay, and at that point a 
diagnosis of dystonic cerebral palsy was made. Since then patient has shown global 
developmental delay, sitting at 10 months, but not walking until after the age of 5. He remains 
non-verbal, communicating with Makaton, but clearly has some understanding of language. 
He has a formal diagnosis of autism spectrum disorder with his developmental delay. He has 
additional behavioural problems and poor sleep. Height and head circumference have 
remained in the normal range, but his weight is persistently on or greater than the 99th centile 
for age. 
 
On examination, he has dysmorphic facial features with synophrys and finely ‘pencilled’ 
eyebrows (Figure G). His palpebral fissures are upslanting. He has a thin lower lip, 
micrognathia and strikingly prominent central incisors. ArrayCGH and other baseline 
investigations for learning difficulties were normal.  
 
Patient 8: This 19-year old female patient is one of twins, the only children of White Welsh 
parents. The patient's twin brother is healthy with no intellectual problems. There is no family 
history of note. The twins were conceived by IVF. The pregnancy was uncomplicated. The 
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patient was born by emergency caesarean section (for failure to progress) at 40 weeks 
gestation. APGAR scores were good. Birth weight was 3090g (25th centile) and head 
circumference was 34.8cm (50th centile). 
 
The patient had early severe feeding problems and was nasogastric tube fed from day one. 
She had recurrent admissions for chest infections in the first year of life and was diagnosed 
with laryngomalacia and gastro-oesophageal reflux.  She was reviewed in the Genetics Clinic 
at 5 months of age she was noted to have mild dysmorphic features (mild synophrys, cupped 
ear helix, down turned mouth), microcephaly, hypotonia and poor weight gain. The patient 
had an operation for intestinal malrotation at 9 months of age. Nasogastric feeding continued 
for 1-2 years. 
 
This patient was noted to have global developmental delay in infancy. She sat at 18 months 
and walked at 8 years. She was diagnosed with autism at 6 years. She was taught with 1:1 
help in a special school. The patient had possible absence seizures from 6 years but developed 
generalised tonic-clonic seizures from 11 years. Her periods began at 12 years.  
 
On examination at 19 years of age, her height was 152cm (2nd centile), weight 37.3kg (<0.4th 
centile) and head circumference 50.4cm (<0.4th centile) and dysmorphic with down-slanting 
palpebral fissures, hypertelorism, and prominent forehead (Figure H). She had mild synophrys 
with lateral upsweep of the eyebrow, prominent nasal bridge and root, a small mouth with 
short philtrum, high palate, bifid uvula, crowded teeth, an overbite, a convergent squint, 
slender feet, pes planus, scaphocephaly and slightly low-set ears. She can walk short 
distances. She has no speech apart from simple sounds but uses a PECS (Picture Exchange 
Communication system) effectively. She uses a spoon to feed herself. Her neurology was 
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difficult to assess but she appears to have low muscle tone. The patient has a bifid nail on her 
left index finger. 
 
Potential diagnoses suggested over the years include: Angelman syndrome, Pitt-Hopkins 
syndrome and Cornelia de Lange syndrome. Extensive metabolic investigation was normal. 
MRI-brain at 1 year showed delayed myelination. This was normal when repeated at 9 years. 
Genetic tests have included: routine karyotype (blood and skin), subtelomeric screening, 
Angelman methylation, TCF4 and array CGH – all normal. 
 
Patient 9: This 4-year old patient was born following a normal pregnancy at 38-weeks 
gestation by elective caesarean section due to breech presentation with a birth weight of 3200 
grams. She was in a good condition immediately after birth and did not need admission to the 
Neonatal unit. She has feeding difficulties in the first year of life which subsequently 
resolved. She went on to have moderate developmental delay with walking at over 1 year of 
age, speech delay and need for special school. 
 
This patient was initially reviewed in the Genetics clinic at 2-years of age. On examination at 
4 years of age, her height was 97 cms (50
th
 centile), weight 12.05 kg (0.4
th
 centile) and ofc 
47.5 cm (0.4
th
 centile); she had hand flapping behaviour with severe speech delay. She had 
distinctive facial features including down-slanting palpebral fissures, fine arched eyebrows, 
prominent forehead, bilateral low-set ears (Figure I). 
 
Patient 10: This 9-year old patient was antenatally diagnosed with mild renal pelvis dilatation 
which subsequently resolved. He was born by elective caesarean section due to extended 
breech presentation at 38-weeks gestation with a birth weight of 3400 grams. He was in a 
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good condition immediately after birth and did not need admission to the Neonatal unit. 
However, he developed significant gastro-oesophageal reflux and failure-to-thrive following 
cessation of breast feeds and had significant feeding issues between 6-8 months of life. 
 
In terms of his development, he was delayed in that he had marked central hypotonia with 
significant head lag persisting until 3 years of age; sat up at 8-months but delayed with his 
walking with unusual gait and dystonic posturing of lower limbs; poor speech relying on 
PECS communication. He currently attends a special needs school and has been diagnosed 
with autism spectrum disorder, attention deficit with previous trial of Methylphenidate and 
Clonidine for stereotypies. In the first couple of years of life, he had frequent colds and cold 
extremities. He has a pleasant disposition with broad smile but has obsessive behaviours and 
high pain threshold. 
 
On examination at 7 years, 7 months of age, his height was 120 cm (25
th
 centile), weight was 
19.4 kg (9
th
 centile) and ofc 50 cm (<0.4
th
 centile) with distinctive facial features including 
up-slanting palpebral fissures, twin hair crowns, high-arched palate and bilateral low-set ears. 
He also had a postural scoliosis needing Lycra suit fitting. MRI-brain and arrayCGH were 
reported as normal 
 
Patient 11: This 19-year old patient was born following a normal pregnancy at 40-weeks 
gestation with a birth weight of 3400 grams by normal delivery. She developed a febrile 
episode on day 5 needing neonatal admission. She also had significant feeding difficulties 
with frequent vomiting episodes.  
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In terms of her development, she was delayed in that she had marked central hypotonia with 
head lag, she sat independently at 2 years 4 months and walked at 5 years with an unsteady 
gait. She is non-verbal and attends a special needs school. Her behaviour is complicated by 
bruxism, grunting, mouthing of hands, intermittent eye contact. She also developed 
generalised seizures as a child which have now resolved.  
 
On examination at 11.5 years of age, her height was 136.4 cm (9
th
 centile), weight was 26.3 
kg (2
nd
 centile) and ofc 52 cm (0.4
th
 centile), she is extremely slim with long limbs, 
arachnodactyly, malar hypoplasia, a high-arched narrow palate and down-slanting palpebral 
fissures. 
 
Patient 12: This 8-year old patient was born following a normal pregnancy at 38-weeks 
gestation by elective caesarean section due to breech presentation. He was in a good condition 
immediately after birth but went on to have mild feeding difficulties not needing any 
intervention.  
 
In terms of his development, he was delayed in that he developed social smile at 3-months of 
age, sat independently at 18-months of age, walked with support at 3 years and independently 
at 5 years of age but has no speech. He attends a special needs school and is said to be 
generally placid with a diagnosis of autism spectrum disorder.  
 
On examination at 8 years of age, his height and ofc were on the 50
th
 centile and weight on 
the 25
th
 centile with a high-arched palate, down-slanting palpebral fissures and hypotonia 
(Figure J).  
